Table 1.

Organ weights after administration of OTA (0, 70, 210 μg/kg body weight) for 2, 4, 13 and 26 weeks

Time (weeks)	Dose (μg/kg)	Liver (g)	Kidney (g)	Spleen (g)	Testicle (g)
2	0	5.59 ± 0.44	1.40 ± 0.12	0.46 ± 0.02	2.28 ± 0.09
	70	6.35 ± 0.43 a	1.56 ± 0.09 a	0.44 ± 0.04	2.37 ± 0.20
	210	5.83 ± 0.75	1.40 ± 0.11 b	0.43 ± 0.06	2.49 ± 0.35
4	0	6.19 ± 0.80	1.57 ± 0.14	0.45 ± 0.04	2.55 ± 0.12
	70	6.18 ± 1.33	1.57 ± 0.21	0.46 ± 0.07	2.56 ± 0.28
	210	5.98 ± 0.79	1.43 ± 0.12	0.43 ± 0.04	2.63 ± 0.07
13	0	8.06 ± 1.43	2.03 ± 0.10	0.56 ± 0.79	2.93 ± 0.06
	70	6.84 ± 0.68	1.83 ± 0.12 a	0.54 ± 0.05	3.00 ± 0.20
	210	6.86 ± 0.70	1.51 ± 0.74 ab	0.50 ± 0.46	2.83 ± 0.17
26	0	7.48 ± 0.72	2.02 ± 0.24	0.54 ± 0.06	3.13 ± 0.25
	70	8.11 ± 0.96	2.04 ± 0.14	0.58 ± 0.06	3.20 ± 0.11
	210	6.72 ± 0.68 b	1.67 ± 0.19 ab	0.54 ± 0.07	3.10 ± 0.16

a: p < 0.05, compared to 0 μg/kg b.w. group; b: p < 0.05, compared to 70 μg/kg b.w. group.